D
Regeneron Pharmaceuticals, Inc. REGN
$589.48 -$8.68-1.45% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
52-Week Range
P/E (TTM)
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Net Income -2.84% 12.01% -20.86% 33.02% 47.90%
Total Depreciation and Amortization 11.93% 11.22% 11.86% 15.46% 17.07%
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items 46.85% -108.52% 351.11% -155.43% -1,002.17%
Change in Net Operating Assets 74.91% -70.58% -40.72% 66.77% -1,017.47%
Cash from Operations 223.28% -30.90% 15.89% 15.88% -65.38%
Capital Expenditure -21.33% -71.25% 20.60% -37.44% -59.73%
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -202.63% 100.00% --
Divestitures -- -- -- -- --
Other Investing Activities -123.33% 156.45% 197.20% -23.51% 82.77%
Cash from Investing -96.34% 138.38% 629.61% -15.74% 76.66%
Total Debt Issued -- -- -- -- --
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock -92.80% -91.12% -69.80% -5.17% 382.47%
Repurchase of Common Stock -16.53% -64.68% -64.15% -26.54% -29.90%
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash from Financing -135.98% -2,412.53% -154.54% -55.66% 22.16%
Foreign Exchange rate Adjustments 233.33% 220.00% -450.00% 500.00% 25.00%
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash -58.07% 571.88% -17.38% -60.29% 65.56%